Optimizing Care in PBC: Evolving Evidence and Practical Strategies for Individualizing Second-Line Therapy

Primary biliary cholangitis (PBC) is a progressive autoimmune liver disease that can lead to cirrhosis, hepatic decompensation, and transplantation if not effectively managed. Although first-line therapies improve outcomes for many patients, a substantial proportion experience insufficient biochemical response and/or inadequate symptom control, leaving them at ongoing risk for disease progression and impaired quality of life. Early identification of patients who may benefit from second-line therapy, along with individualized treatment selection, is essential to improving long-term outcomes. Watch this video featuring an international panel of PBC experts to: Hear firsthand, real-world perspectives from a patient living with PBCDiscuss practical strategies for personalized PBC care Review the latest efficacy and safety data on second-line therapies Explore approaches to individualizing treatment plans for key PBC patient subpopulations Preview and download a new point-of-care resource designed to support personalized PBC management. Don’t miss this opportunity to gain actionable insights that can elevate your approach to PBC care and drive better patient outcomes.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Target Specialties

Pricing

Free

Reported to ACCME by the provider

On-demand / recorded video
Credit · Up to 1 credit
Commercial Support

Released

Mar 27, 2026
Last day to claim credit

Mar 27, 2027 6 months left

Optimizing Care in PBC: Evolving Evidence and Practical Strategies for Individualizing Second-Line Therapy

Related courses

More from PRIME Education, Inc. (PRIME®)